The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Focal disruption of the blood–brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery
Abstract
Object: The goal of this study was to explore the feasibility of using low-frequency magnetic resonance (MR) image–guided focused ultrasound as a noninvasive method for the temporary disruption of the blood–brain barrier (BBB) at targeted locations. Methods: Rabbits were placed inside a clinical 1.5-tesla MR imaging unit, and sites in their brains were targeted for 20-second burst sonications (frequency 260 kHz). The peak pressure amplitude during the burst varied between 0.1 and 0.9 MPa. Each sonication was performed after an intravenous injection of an ultrasound contrast agent (Optison). The disruption of the BBB was evaluated with the aid of an injection of an MR imaging contrast agent (MAG-NEVIST). Additional tests involving the use of MION-47, a 20-nm magnetic nanoparticle contrast agent, were also performed. The animals were killed at different time points between 3 minutes and 5 weeks postsonication, after which light or electron microscopic evaluation was performed. The threshold for BBB disruption was approximately 0.2 MPa. More than 80% of the brain sites sonicated showed BBB disruption when the pressure amplitude was 0.3 MPa; at 0.4 MPa, this percentage was greater than 90%. Tissue necrosis, ischemia, and apoptosis were not found in tissue in which the pressure amplitude was less than 0.4 MPa; however, in a few areas of brain tissue erythrocytes were identified outside blood vessels following exposures of 0.4 MPa or higher. Survival experiments did not show any long-term adverse events. Conclusions: These results demonstrate that low-frequency ultrasound bursts can induce local, reversible disruption of the BBB without undesired long-term effects. This technique offers a potential noninvasive method for targeted drug delivery in the brain aided by a relatively simple low-frequency device.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits
Hynynen, K., McDannold, N., Vykhodtseva, N., & Jolesz, F. A. (2001) · Radiology · doi:10.1148/radiol.2202001804 · Cited by 1,456
Self-citationComprehensive compilation of empirical ultrasonic properties of mammalian tissues
Goss, S. A., Johnston, R. L., & Dunn, F. (1978) · The Journal of the Acoustical Society of America · doi:10.1121/1.382016 · Cited by 1,115
Hynynen, K., McDannold, N., Sheikov, N. A., Jolesz, F. A., & Vykhodtseva, N. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.046 · Cited by 679
Self-citationSheikov, N., McDannold, N., Vykhodtseva, N., Jolesz, F., & Hynynen, K. (2004) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2004.04.010 · Cited by 617
Self-citationAubry, J.-F., Tanter, M., Pernot, M., Thomas, J.-L., & Fink, M. (2003) · The Journal of the Acoustical Society of America · doi:10.1121/1.1529663 · Cited by 581
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
KrolI, R. A., Neuwelt, E. A., & Neuwelt, E. A. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00082 · Cited by 581
Transporting therapeutics across the blood-brain barrier
Abbott, N. J., & Romero, I. A. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88720-x · Cited by 447
Demonstration of Potential Noninvasive Ultrasound Brain Therapy Through an Intact Skull
Hynynen, K., & Jolesz, F. A. (1998) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(97)00269-x · Cited by 446
Self-citationDrug and Gene Delivery to the Brain
Pardridge, W. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)01054-1 · Cited by 405
Compilation of empirical ultrasonic properties of mammalian tissues. II
Goss, S. A., Johnston, R. L., & Dunn, F. (1980) · The Journal of the Acoustical Society of America · doi:10.1121/1.384509 · Cited by 387
Hynynen, K., Clement, G. T., McDannold, N., Vykhodtseva, N., King, R., White, P. J., Vitek, S., & Jolesz, F. A. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20118 · Cited by 340
Self-citationHigh-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo
Mesiwala, A. H., Farrell, L., Wenzel, H. J., Silbergeld, D. L., Crum, L. A., Winn, H. R., & Mourad, P. D. (2002) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(01)00521-x · Cited by 271
Vykhodtseva, N. I., Hynynen, K., & Damianou, C. (1995) · Ultrasound in Medicine & Biology · doi:10.1016/0301-5629(95)00038-s · Cited by 230
Self-citationThermal effects of focused ultrasound on the brain: determination with MR imaging.
Hynynen, K., Vykhodtseva, N. I., Chung, A. H., Sorrentino, V, Colucci, V, & Jolesz, F. A. (1997) · Radiology · doi:10.1148/radiology.204.1.9205255 · Cited by 229
Self-citationMcDannold, N., Vykhodtseva, N., Jolesz, F. A., & Hynynen, K. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20060 · Cited by 186
Self-citationSun, J., & Hynynen, K. (1999) · The Journal of the Acoustical Society of America · doi:10.1121/1.426863 · Cited by 139
Self-citationHynynen, K., & Sun, J. (1999) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/58.764862 · Cited by 128
Self-citationMorphology and Molecular Properties of Cellular Components of Normal Cerebral Vessels
Nag, S. (2003) · Humana Press eBooks · doi:10.1385/1-59259-419-0:3 · Cited by 100
A numerical study of transcranial focused ultrasound beam propagation at low frequency
Yin, X., & Hynynen, K. (2005) · Physics in Medicine and Biology · doi:10.1088/0031-9155/50/8/013 · Cited by 97
Self-citationIn vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound.
Bednarski, M. D., Lee, J. W., Callstrom, M. R., & Li, K. C. (1997) · Radiology · doi:10.1148/radiology.204.1.9205257 · Cited by 89
Ultrasound and the Blood-Brain Barrier
Patrick, J. T., Nolting, M. N., Goss, S. A., Dines, K. A., Clendenon, J. L., Rea, M. A., & Heimburger, R. F. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5766-7_36 · Cited by 68
Blood–Brain Barrier Permeability Using Tracers and Immunohistochemistry
Nag, S. (2003) · Humana Press eBooks · doi:10.1385/1-59259-419-0:133 · Cited by 60
Improved selective, simple, and contrast staining of acidophilic neurons with vanadium acid fuchsin
Victorov, I. V., Prass, K., & Dirnagl, U. (2000) · Brain Research Protocols · doi:10.1016/s1385-299x(00)00004-0 · Cited by 53
Lo, E. H., Pan, Y., Matsumoto, K., & Kowall, N. W. (1994) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(94)92533-x · Cited by 47
Cited by
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
McDannold, N., Arvanitis, C. D., Vykhodtseva, N., & Livingstone, M. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0128 · Cited by 588
Self-citationDrug Delivery Systems, CNS Protection, and the Blood Brain Barrier
Upadhyay, R. K. (2014) · BioMed Research International · doi:10.1155/2014/869269 · Cited by 528
Kievit, F. M., & Zhang, M. (2011) · Advanced Materials · doi:10.1002/adma.201102313 · Cited by 496
Metadata
- Authors
- Hynynen, K., McDannold, N., Vykhodtseva, N., Raymond, S., Weissleder, R., Jolesz, F. A., & Sheikov, N.
- Venue
- Journal of Neurosurgery
- Published
- 2006-09
- Volume
- 105
- Issue
- 3
- Pages
- 445-454
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W1973652084
- Cited by
- 314
- References
- 25
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.